Back to Search Start Over

[Hyperviscosity syndrome].

Authors :
Dumas G
Merceron S
Zafrani L
Canet E
Lemiale V
Kouatchet A
Azoulay E
Source :
La Revue de medecine interne [Rev Med Interne] 2015 Sep; Vol. 36 (9), pp. 588-95. Date of Electronic Publication: 2015 Mar 13.
Publication Year :
2015

Abstract

Hyperviscosity syndrome is a life-threatening complication. Clinical manifestations include neurological impairment, visual disturbance and bleeding. Measurement of plasma or serum viscosity by a viscometer assesses the diagnosis. Funduscopic examination is a key exam because abnormalities are well-correlated with abnormal plasma viscosity. Etiologies are various but symptomatic hyperviscosity is more common in Waldenström's macroglobulinemia and multiple myeloma. Prompt treatment is needed: treatment of the underlying disease should be considered, but generally not sufficient. Symptomatic measures aim to not exacerbate blood viscosity while urgent plasmapheresis effectively reduces the paraprotein concentration and relieves symptoms.<br /> (Copyright © 2015 Société nationale française de médecine interne (SNFMI). Published by Elsevier SAS. All rights reserved.)

Details

Language :
French
ISSN :
1768-3122
Volume :
36
Issue :
9
Database :
MEDLINE
Journal :
La Revue de medecine interne
Publication Type :
Academic Journal
Accession number :
25778852
Full Text :
https://doi.org/10.1016/j.revmed.2015.02.005